Abstract

Ofatumumab is a feasible alternative anti-CD20 therapy in patients intolerant of rituximab.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
FRI0126 THE INFUSION-RELATED REACTIONS OF RITUXIMAB IN RHEUMATIC DISEASES: SINGLE-CENTER EXPERIENCE OF 1893 INFUSIONS OVER 5 YEARS
Kung-Yu Wang ... Li Ko-Jen
-
Kung-Yu Wang, et. al.Kung-Yu Wang ... Li Ko-Jen
01 Jun 2019
Grading of Neurotoxicity in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL) Receiving Tisagenlecleucel Treatment in the JULIET Study
Vadim V Romanov ... Richard T Maziarz
Blood | VOL. 132
Vadim V Romanov, et. al.Vadim V Romanov ... Richard T Maziarz
29 Nov 2018
Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials.
Deirdre R Pachman ... Charles L Loprinzi
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | VOL. 25
Deirdre R Pachman, et. al.Deirdre R Pachman ... Charles L Loprinzi
20 Jun 2017
Use of Montelukast to Reduce Infusion Reactions in an Early Access Treatment Protocol of Daratumumab in United States Patients with Relapsed or Refractory Multiple Myeloma
Jon Ukropec ... Thomas Lin
Blood | VOL. 128
Jon Ukropec, et. al.Jon Ukropec ... Thomas Lin
02 Dec 2016
View more papers

More From: British journal of haematology

Paper Title
Journal
Date
Author
Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T-cell therapy in Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Tamer Othman ... Ibrahim Aldoss
British journal of haematology | VOL. -
Tamer Othman, et. al.Tamer Othman ... Ibrahim Aldoss
29 May 2024
Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I-BFM Study Group.
Herbert Pichler ... Adriana Balduzzi
British journal of haematology | VOL. -
Herbert Pichler, et. al.Herbert Pichler ... Adriana Balduzzi
27 May 2024
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP.
Douglas A Stewart ... Michael Crump
British journal of haematology | VOL. -
Douglas A Stewart, et. al.Douglas A Stewart ... Michael Crump
27 May 2024
RUNX1::ETO and CBFβ::MYH11 converge on aberrant activation of BCAT1 to confer a therapeutic vulnerability in core-binding factor-acute myeloid leukaemia.
Siyang Wang ... Kankan Wang
British journal of haematology | VOL. -
Siyang Wang, et. al.Siyang Wang ... Kankan Wang
27 May 2024
View more papers